Core Scientific, Inc./tx (CORZW) Common Equity (2020 - 2026)

Core Scientific (CORZW) has 7 years of Common Equity data on file, last reported at -$1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 322.8% year-over-year to -$1.3 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.3 billion (down 322.8% YoY), and the FY2025 full-year result was -$962.7 million, down 2.09% from the prior year.
• Common Equity fell to -$1.3 billion in Q1 2026, from -$962.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.1 billion in Q1 2022 to a low of -$1.3 billion in Q1 2026.
• A 5-year average of -$522.9 million and a median of -$418.7 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 1059.68% in 2022 and plunged 673.39% in 2023, its largest moves.
• Tracing CORZW's Common Equity over 5 years: stood at -$409.3 million in 2022, then tumbled by 45.83% to -$596.9 million in 2023, then sank by 57.98% to -$943.0 million in 2024, then dropped by 2.09% to -$962.7 million in 2025, then plunged by 35.62% to -$1.3 billion in 2026.
• Business Quant data shows CORZW's Common Equity at -$1.3 billion in Q1 2026, -$962.7 million in Q4 2025, and -$1.3 billion in Q3 2025.